Clinical trial of botulinum toxin type A therapy in patients with Japanese cedar pollinosis 2014

Clinical trial of botulinum toxin type A therapy in patients with Japanese cedar pollinosis 2014 - Effect of Botulinum Toxin Type A Therapy in Patients with Jananese cedar polloniosis(E-Boat study 4)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013007

Enrollment

Registered

2014-02-10

Start date

2014-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese cedar pollinosis

Interventions

One-point-six ml (40U) of botulinum toxin type A soaked cotton sponge is inserted into each nostril and placed on nasa mucosa for 15 to 20min, then removed. anti-histamine tablet and/or eye drops can

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a history of Japnese cedar pollinosis in each year and CAP-RAST ageinst Japanese cedar pollen >=2

Exclusion criteria

Exclusion criteria: 1)pregnacy 2)during breast feeding 3)history of heart disease 4)history of neuro-muscular disease 5)history of nasal surgery 6)prominent deviation of the nasal septum

Design outcomes

Primary

Measure	Time frame
Symptom score, Symptom-Medication score, Numeric Rating Scale	—

Secondary

Measure	Time frame
Adverse events Medication Score	—

Countries

Japan

Contacts

Public ContactA

Saitama Medical University Otorhinolaryngology

atkamijo@saitama-med.ac.jp049-276-1253

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026